Back to Search
Start Over
MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)
- Source :
- Journal of Thoracic Oncology. 12:S1864-S1865
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Chemotherapy
TGF alpha
Bevacizumab
business.industry
medicine.medical_treatment
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
Non small cell
business
Lung cancer
medicine.drug
Subjects
Details
- ISSN :
- 15560864
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- Journal of Thoracic Oncology
- Accession number :
- edsair.doi...........56f32260997fc6a9c420cdf39e82e2ba